Article de revue

Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study

Little is known about how long the BCG vaccine protects against tuberculosis. This study assessed the long-term vaccine effectiveness (VE) in Norwegian-born individuals.

Langues

  • Anglais

Année de publication

2016

Journal

The Lancet Infectious Diseases

Volume

2

Type

Article de revue

Catégories

  • Prestation de services

Maladies

  • Tuberculose

Pays

  • Norvège

Mots-clés

  • Coverage monitoring

Régions de l'OMS

  • Région européenne